Assessment of the New Automated Vitrification System "GAVI" for Early Cleaved Embryos Cryopreservation

Sponsor
University Hospital, Toulouse (Other)
Overall Status
Completed
CT.gov ID
NCT03478592
Collaborator
(none)
423
1
2
36.5
11.6

Study Details

Study Description

Brief Summary

The meta-analysis comparing the cryopreservation of human embryos by vitrification or slow-freezing suggested that more well design studies as randomized trials are necessary to identify the most successful method for cryopreservation. The efficacy of the vitrification with the GAVI system will be compared with the conventional slow freezing method through a randomized control trial. Couples in IVF attempt will be randomized at the day of embryo cryopreservation by the biologist. Supernumerary frozen embryos will be thawed and transferred in utero in case of failure of the "fresh" embryo transfer. The outcomes of the thawing and frozen/thawed embryo transfer will be assessed. In the two groups, the patients will benefit of the standard IVF procedures applied in the Assisted Reproductive Technologies (ART) center of Toulouse.

Condition or Disease Intervention/Treatment Phase
  • Other: reference technique
  • Other: vitrification technique
N/A

Detailed Description

The last decade has seen a development of a new cryopreservation technique called vitrification. Despite a lack of randomized control trials comparing slow-freezing and vitrification, vitrification seems to show better recovery rates and pregnancy outcomes. However vitrification is a manual, labour-intensive and highly skilled procedure, results can vary between embryologists and clinics. The GAVI system, an automation instrument with a novel closed system device has been developed. The present study would like to assess the outcomes for embryos automatically vitrification processed with the GAVI system compared with those processed with conventional reference technique of slow freezing.

The meta-analysis comparing the cryopreservation of human embryos by vitrification or slow-freezing suggested that more well design studies as randomized trials are necessary to identify the most successful method for cryopreservation. The efficacy of the vitrification with the GAVI system will be compared with the conventional slow freezing method through a randomized control trial. Couples in IVF attempt will be randomized at the day of embryo cryopreservation by the biologist. Supernumerary frozen embryos will be thawed and transferred in utero in case of failure of the "fresh" embryo transfer. The outcomes of the thawing and frozen/thawed embryo transfer will be assessed. In the two groups, the patients will benefit of the standard IVF procedures applied in the Assisted Reproductive Technologies center of Toulouse.

Study Design

Study Type:
Interventional
Actual Enrollment :
423 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Investigator)
Primary Purpose:
Treatment
Official Title:
Assessment of the New Automated Vitrification System "GAVI" for Early Cleaved Embryos Cryopreservation
Actual Study Start Date :
Jan 19, 2018
Actual Primary Completion Date :
Feb 3, 2021
Actual Study Completion Date :
Feb 3, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: reference technique slow freezing

In reference technique slow freezing arm, embryon will be frozen with the conventional slow freezing procedure with the Freezal device apply a slow decreasing in temperature with moderate cryoprotector concentration

Other: reference technique
Slow-freezing procedure is the reference technique, actually use at the Toulouse hospital, to cryopreserve embryos. Embryon are frozen with a slow freezing.

Experimental: vitrification technique

In vitrification technique arm, embryon will be frozen with automated vitrification system

Other: vitrification technique
Vitrification is the new technique to freeze embryons. In this study, the GAVI system will be use for for embryos automatically vitrification

Outcome Measures

Primary Outcome Measures

  1. Implantation rate of frozen/thawed embryos [1 month]

    The number of implantation embryo with cardiac activity in reference technique and in vitrification technic

Secondary Outcome Measures

  1. Percentage of intact blastomeres after thawing [1 month]

    It will be measured by microscopic evaluation by a biologist or an IVF laboratory technician at the time of thawing, routine very simple laboratory to do because at this early embryonic stage there are few cells: 4 to 8 cells and they are well individualized.

  2. Implantation rate of transferred embryos. [1 month]

    number of implantation of transferred embryos in both technique

  3. Live birth rates [9 months after the implantation]

    Number of live birth for reference technique and for vitrification technique

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Couple whose age is > 18 years and who are included in a IVF procedure with the possibility to cryopreserve embryos according to criteria applied at the hospital of Toulouse

  • Signed informed consent by both partners in a couple

  • Affiliation to a social security scheme for both partners of the couple

Exclusion Criteria:
  • Couples who does not meet current requirements described by the bioethics law for accession to the ART procedure

  • Positive plasma viral load for HIV, hepatitis C virus or hepatitis B virus during the year before the inclusion in one of the couple.

  • One of the two partners (or both) is (are) in safeguarding justice, under guardianship or trusteeship.

  • Couple included in another interventional study.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hospital university of Toulouse Toulouse France 31059

Sponsors and Collaborators

  • University Hospital, Toulouse

Investigators

  • Principal Investigator: Roger LĂ©andri, MD, University Hospital, Toulouse

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital, Toulouse
ClinicalTrials.gov Identifier:
NCT03478592
Other Study ID Numbers:
  • RC31/16/8766
First Posted:
Mar 27, 2018
Last Update Posted:
Oct 28, 2021
Last Verified:
Oct 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University Hospital, Toulouse

Study Results

No Results Posted as of Oct 28, 2021